QualityStocksNewsBreaks – CytoDyn Inc. (CYDY) Management Presenting at Two Upcoming Investment Conferences
CytoDyn (OTCQB: CYDY), a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, this morning announced…